Source: http://docplayer.net/705657-Review-of-drug-and-alcohol-treatments-in-prison-and-community-settings.html
Timestamp: 2017-03-25 08:15:44
Document Index: 67866079

Matched Legal Cases: ['art 1', 'art 1', 'art 1', 'art 1', 'art 1', 'art 1', 'art 1', 'art 1']

Review of Drug and Alcohol Treatments in Prison and Community Settings - PDF
Review of Drug and Alcohol Treatments in Prison and Community Settings
Download "Review of Drug and Alcohol Treatments in Prison and Community Settings"
August Barrett
1 Review of Drug and Alcohol Treatments in Prison and Community Settings A Systematic Review Conducted on Behalf of the Prison Health Research Network Amanda J Roberts, Adrian J Hayes, Julie Carlisle & Jenny Shaw The University of Manchester November 2007 This project was commissioned and funded by Offender Health in the Department of Health, via the Prison Health Research Network. Thanks to Maria Leitner, Wally Barr, Nat Wright, Mike Farrell, Charlie Brooker, David Marteau and Jane Senior for invaluable assistance during the writing of this report. 12 TABLE OF CONTENTS EXECUTIVE SUMMARY...3 RATIONALE...16 SECTION 1: REVIEW OF CURRENT POLICY AND GUIDANCE PRISON AND OFFENDER COMMUNITY...27 SECTION 2: REVIEW OF DRUG TREATMENTS REVIEW OF OFFENDER TREATMENTS...33 Fazel et al (2006)...34 Perry et al (2006)...38 Holloway et al (2005) REVIEW OF COMMUNITY TREATMENTS...55 Opioid Abuse and Dependence...55 Cocaine Abuse and Dependence...67 Amphetamine and amphetamine type stimulants (ATS) abuse and dependence...71 Cannabis Abuse and Dependence...73 Iatrogenic use of prescribed drugs...74 Polydrug...75 SECTION 3: REVIEW OF ALCOHOL TREATMENTS REVIEW OF OFFENDER TREATMENTS...79 Aims...79 Method...79 Results...82 Narrative Review...83 Summary Conclusions by Treatment Type...99 Summary Conclusions by Study Quality Discussion REVIEW OF COMMUNITY TREATMENTS Pharmacological Interventions Psychosocial Interventions Preventative Interventions SECTION 4: CONCLUSIONS REFERENCES APPENDIX 1: ACCREDITED OFFENDING BEHAVIOUR PROGRAMMES RELATING TO SUBSTANCE MISUSE APPENDIX 2: EFFECTIVENESS OF TREATMENTS INCLUDED IN THE 24 RCTS IN PERRY ET AL (2006) BY TYPE OF INTERVENTION APPENDIX 3: EFFECTIVENESS OF TREATMENTS INCLUDED IN THE STUDIES REPORTED IN HOLLOWAY ET AL (2005) BY TYPE OF INTERVENTION APPENDIX 4: RESULTS OF META-ANALYSIS OF POST-TEST ONLY STUDIES INCLUDED IN HOLLOWAY ET AL APPENDIX 5: RESULTS OF META-ANALYSIS OF PRE-POST TEST ONLY STUDIES WITH CONTROLS INCLUDED IN HOLLOWAY ET AL APPENDIX 6: RESULTS OF TREATMENT EFFECTIVENESS OF INCLUDED STUDIES CATEGORISED BY TYPE OF TREATMENT APPENDIX 7: GENDER OF PARTICIPANTS IN THE INCLUDED STUDIES APPENDIX 8: REFERENCES OF EXCLUDED STUDIES FROM THE ALCOHOL REVIEW WITH REASONS FOR EXCLUSION3 Executive Summary Rationale Substance misuse is a major problem in the general population as well as in prisons and the wider Criminal Justice System (CJS). Whilst there is a large body of evidence for community-based drug treatments, there has been far less research in criminal justice settings. We outline the recent in-depth reviews of offender-based drug treatments. Within the field of substance misuse, alcohol is not often considered separately. We have therefore conducted a new systematic review of alcohol treatments in offender populations. In both areas, we have also considered the evidence for community-based treatment interventions and highlighted gaps in relevant prison research. Section 1: Background There are several policy documents and strategies for the management and treatment of problematic substance users in offender populations. The National Offender Management Service (NOMS) has a strategy relating to problematic drug users in correctional services (NOMS, 2005). HM Prison Service have in place drug and alcohol strategies (HMPS, 2002; HMPS 2003; HMPS, 2006), as well as a good practice guide for alcohol treatment and interventions (HMPS, 2004). The National Probation Service also has a strategy for working with alcohol misusing offenders (National Probation Service, 2006). Finally, the cross-government document Safe. Sensible. Social (2007), updating the national alcohol strategy, contains specific recommendations for offender populations. Section 2: Review of Drug Treatments This section begins with a summary of three systematic reviews specifically relating to substance misuse in offender settings. These recent and comprehensive reviews have been critically appraised in this section with their conclusions described at some length. Following this, there is a summary of 34 the evidence for treatments in community settings, with potential gaps for offender-based research highlighted. 2.1 Review of Offender Treatments Three systematic reviews of substance misuse and dependence in prison and/or offender populations have been published in the last three years. Fazel et al (2006) aimed to determine the prevalence of substance abuse/dependence in prisons, and to compare this with the general population. Perry et al (2006) aimed to establish the effect of offender treatments on continued drug use and reoffending, in a variety of settings including courts, secure care, and in the community. Finally, Holloway et al (2005) examined the effect of criminal justice and drug programmes on drugrelated crime. Fazel et al (2006) The basis for this review was to explore the relationship between offending behaviours and substance abuse in various criminal and medical settings. Fazel et al (2006) suggested that a greater understanding of the extent of substance abuse and dependence in offenders would aid the development of appropriate services and inform treatment interventions. Therefore, a systematic review was conducted to ascertain the prevalence rates of substance abuse/dependence in prisoners and to compare prevalence rates with that of the general population. Overall, it was concluded that the prevalence estimates of drug/alcohol abuse/dependence for prisoners is higher than in the general population. North American figures revealed that male prisoners had slightly higher (but not significant) rates of alcohol dependency while drug dependency was 2 to 10 times higher than the general population. For female prisoners, differences were more marked: Alcohol dependency was 2 to 10 times higher and drug dependency up to 13 times higher than that of females in the general population. Fazel et al (2006) therefore suggested that service provision for female prisoners should be a priority. However, further research into the 45 prevalence of alcohol abuse/dependence in females outside the US is needed before adequate recommendations can be made for the provision of treatment services. Perry et al (2006) The research question in this review explored whether; (i) court based interventions, (ii) secure establishment-based interventions, and (iii) community-based interventions for drug misusing offenders reduce drug use and/or criminal activity? Therapeutic communities and aftercare seemed to be the most promising of interventions. However, the studies that reported these findings were quasiexperimental and may have included some bias: More robust designs are needed to elucidate these results. Given the methodological weaknesses of the studies, very limited conclusions on treatment success can be drawn from this review. It is apparent, however, that there is no single gold standard treatment intervention. Furthermore, limited conclusions can be drawn as to the cost effectiveness of treatment interventions for drug misusing offenders with only one study including economic evaluations. Therefore, Perry et al (2006) suggested a need to conduct better quality research that utilises standardised outcome measures which will enable comparisons to be made across literature. Holloway et al (2005) In direct response to the proposals made in the Updated Drug Strategy 2002 (Home Office 2002), Holloway et al (2005) systematically reviewed the literature on the effectiveness of (i) criminal justice programmes that aim to directly reduce drug related crime, or (ii) drug treatment programmes that as a consequence may indirectly serve to reduce drug related crime. Four major conclusions can be drawn. Firstly, most drug interventions seemed to work in reducing drug related crime. Meta-analyses showed all programmes to be effective. Forty-four of the 56 52 studies in the quantitative narrative review found the programme under study was effective in reducing drug related crime on at least one measure. Secondly, methadone treatment, heroin treatment, therapeutic communities, psychosocial approaches, drug courts and probation and parole supervision seemed to be more effective than supervision and aftercare, drug testing, and other criminal justice approaches. Holloway et al (2005) suggested that some findings are based on a small number of studies with small sample sizes and therefore findings should be treated with caution. It is also important to be aware that some programmes work for some offenders and not others. Thirdly, it seemed that programme outcome is related to demographic characteristics of the individual. In order for results to be more informative studies would need to be conducted that directly investigate the interaction between the treatment programme and individuals demographic characteristics. However, the review demonstrated that many programmes were more effective for males than females and that younger people were more responsive to the treatment interventions than older people. The latter finding highlights a possible need for early intervention for drug treatment programmes in order to potentially prevent later recidivism. The final conclusion that can be drawn from the review relates to programme intensity. The meta-analyses showed that higher intensity programmes were 50% more likely to reduce criminal behaviour than their low intensity equivalents. The quantitative narrative review showed that for 4 out of 11 studies evaluating methadone treatments, those administering higher continuous injected dosages showed greater reductions in offending and, when coupled with maximum supervision and aftercare following the drug treatment programme, reduced crime by 90% as opposed to 57% among the group who received minimum aftercare. Holloway et al (2005) stressed the need for good quality research to be conducted on the effectiveness of treatment programmes for drug-misusing offenders in the UK. Additionally the authors appealed to researchers to 67 investigate the causal mechanisms via the construction of possible theoretical reasons for the effectiveness of treatment programmes in reducing later criminal activity. Herein lies an opportunity for more qualitative and longitudinal research to follow offenders progress as they are receiving treatment interventions from a user perspective. Holloway et al (2005) suggested that government policy is not prescriptive enough in its promotion of the specific interventions needed in order to tackle drug misuse and subsequently achieve the objectives set out in the Updated Drugs Strategy 2002 (Drugs Strategy Directorate, 2002). They suggested that prioritising the treatment interventions shown to be effective would be fruitful in achieving this objective. 2.2 Review of Community Treatments This section is based on published Cochrane reviews of community-based drug treatments. Opioids Abuse and Dependence Pharmacological Detoxification Interventions Treatment with buprenorphine has been demonstrated to be successful for opioid detoxification when compared to clonidine. Furthermore, clonidine and lofexidine detoxification did not differ in effectiveness from reducing doses of methadone. Methadone at tapering doses assisted withdrawal symptoms but did not prevent relapse. The use of opioid antagonists (such as naltrexone and naloxone) was shown to be feasible, but the level of success was not clear, and a high level of monitoring was necessary. The use of heavy sedation during withdrawal was not supported due adverse incidents and cost. Pharmacological Maintenance Interventions The evidence for pharmacological maintenance interventions showed similar effectiveness of buprenorphine and methadone. Furthermore, methadone was preferable to no treatment, and particularly effective at doses of8 mg/day. Levo-Alpha Acetyl Methadol (LAAM) may be more effective than methadone, but concerns over side effects (whilst not demonstrated in the research) have led to its removal from the market in Europe and the US. There was not enough information to draw conclusions on the efficacy of naltrexone or heroin maintenance. Psychosocial Interventions The evidence suggested that psychosocial interventions are effective when combined with pharmacological treatment or maintenance, but not alone. The additional effect seemed to be particularly important in assisting patients to be abstinent in the long term for pharmacological but not maintenance treatment. However, there were difficulties in defining interventions as psychosocial, and in the great variety of available interventions of this type: each type of intervention should be evaluated in large-scale trials examining broad outcomes such as improved social functioning, as well as continued drug use and reoffending. Cocaine Abuse and Dependence To date, no treatments have demonstrated success in treating cocaine dependence. Amphetamine and amphetamine type stimulants (ATS) abuse and dependence No treatments have demonstrated effectiveness in the treatment of those with amphetamine disorders. However, there is limited evidence for reduction in craving symptoms with fluoxetine in the short term, and increased mediumterm adherence in treatment with imipramine. These may represent areas for future research. There have been no reviews of psychosocial or other interventions for amphetamine disorders. Cannabis Abuse and Dependence There is a dearth of evidence in the treatment of cannabis disorders. 89 Iatrogenic use of prescribed drugs The effectiveness of a gradual reduction in benzodiazepine was demonstrated, and the additional use of carbamazepine was suggested. Polydrug Psychosocial Interventions Therapeutic communities have shown some success and are discussed in relation to offenders in Section 2.1. Section 3: Review of Alcohol Treatments This section begins with a new systematic review synthesising the research evidence for alcohol treatments in offender populations. Following this, a summary of Cochrane reviews is presented relating to the treatment of alcohol misuse and dependence in the community. 3.1 Review of Offender Treatments Aims This systematic review summarised the research literature on the effectiveness of treatment and prevention interventions which aim to reduce alcohol use/abuse and/or criminal behaviours in offender populations. Method Nine databases were searched: CINAHL, Embase, Ovid Medline (R), Ovid Medline (R) in process, PsycINFO, Web of Science, ASSIA, Criminal Justice Abstracts and National Criminal Justice Reference Service Abstracts. The terms used were: (i) Alcohol* or Drink* or Drunk* AND (ii) Jail* or Inmate* or Criminal* or Offender* or Incarcerat* or Penitentiar*. The searches were limited to English Language Journals from 1990 onwards. A total of 7003 journal articles were retrieved. Studies were included if they had either a comparison group or a nointervention control group, or if they had used an outcome measure of alcohol use and/or recidivism. Twenty-four articles met the inclusion criteria, and were 910 rated on a scale of methodological quality. Due to the heterogeneity of the studies, meta-analysis was not possible. Therefore a quantitative narrative review was conducted. The treatment interventions were categorised into five groups: Psycho-Social- Behavioural Interventions, Therapeutic Communities (TC), Victim Impact Panels (VIP), interventions involving Legal Sanctions, and Other interventions. Results Four of the 16 studies that included Psycho-Social-Behavioural interventions were effective in reducing both alcohol use/abuse and criminal activity. Two studies evaluated the effectiveness of TCs, only one of which was found to have had a positive effect on the offenders alcohol use. Two studies evaluated the effectiveness of legal sanctions comprising licence suspensions and the fitting of Ignition Interlock devices, and both showed a significant reduction in later alcohol-related driving offences. Interventions comprising VIPs were shown to be largely ineffective with only 1 of the 4 studies evaluated showing a positive effect upon recidivism. Only 1 of the 4 VIP studies evaluated alcohol outcomes and this showed no differences between the VIP group and the non-vip group. The final study evaluating a Vipassana Mindfulness Meditation Intervention was found to be effective in reducing alcohol use but not recidivism. One study showed that after completing a Psycho-Social-Behavioural programme, participants alcohol use increased and the treatment was deemed detrimental. Two studies of Psycho-Social-Behavioural approaches reported increased rates of recidivism post-treatment. 1011 There were 6 randomised controlled studies included in this systematic review. Of the two reported reductions in recidivism, one was a Psycho- Social-Behavioural intervention and the second a Legal Sanctions/Ignition Interlock programme. Two reported positive effects on alcohol use; the first was a Psycho-Social-Behavioural intervention and the second a Therapeutic Community Programme Discussion There is no consistently conclusive evidence for the effectiveness of a single intervention. Opportunities for research with rigorous methodology exist into: whether different treatment interventions work for different types of offenders, by virtue of the type of offence committed, and; which interventions have a sustainable effect to ensure both cost effectiveness and long term benefits to the individuals and society. The methodological quality of the included studies was low, in part due to poor study design and/or due to structural obstacles within the CJS. In particular, studies lacked random allocation, no-treatment comparison groups, and participation was often mandatory. 3.2 Review of Community Treatments Results of four reviews of pharmacological interventions showed success of benzodiazepines for withdrawal, particularly seizures, and also fast and effective results of psychotropic analgesic nitrous oxide as an alternative to benzodiazepine. Trials of anticonvulsant treatment showed too much heterogeneity for success to be determined. The one available review of alcohol dependence showed short-term success of naltrexone as a short-term treatment, and no demonstrated success for nalmefene. Two reviews of psychosocial interventions showed reductions of alcohol consumption for men undergoing brief interventions, but no demonstrated efficacy of Alcoholics Anonymous or other 12-step programmes. 1112 One review of preventative treatments found many interventions to be ineffective. Section 4: Discussion The three existing systematic reviews of offender-based drug treatments and the new review of alcohol treatments presented here all suffer from a dearth of high-quality research in this area, and particularly clinical trials from the UK. Fazel et al (2006) concluded that prisoners have higher rates of substance abuse/dependence than found in the community, though the majority of studies on which the finding is based were conducted in the US. An initial research gap is to carry out a similar review amongst other offender populations such as those in contact with courts, police and probation. Furthermore, no prison-based research has so far been carried out into pharmacological treatment of alcohol withdrawal or dependence. Findings of community-based psycho-social interventions have clear implications for prisons, particularly the effectiveness of Alcoholics Anonymous groups. The efficacy of brief interventions for alcohol use should also be trialled, perhaps for prisoners soon to be released. Policy documents too have highlighted the lack of evidence for some recommended interventions such as brief psycho-social sessions focusing on advice, information and support. The evidence from community settings shows that psychosocial interventions are effective for opioid dependence only when delivered in combination with pharmacological detoxification treatment. The pharmacological evidence base for treating offender populations is severely lacking in the England and Wales. The evidence for treating dependence on substances other than opioids shows very limited success to date in community settings, and is non-existent in offender settings. One area where there is an evidence base for offender populations is therapeutic communities. Prison therapeutic communities may be favourable to prison 1213 alone or other treatment programmes, but the studies that have been conducted are lacking in methodological quality. Holloway et al s (2005) review was more promising, showing that most interventions into drug treatments seemed to have a positive impact on reducing drug-related crime. Whilst caveats of research quality should be kept in mind, the review showed that methadone treatment, heroin treatment, therapeutic communities, psychosocial approaches, drug courts and probation/parole supervision seemed to be more effective than supervision and aftercare, drug testing and other criminal justice approaches. There should be a move to prioritise (and invest in) the specific approaches with demonstrable success. Alcohol misuse has often been assimilated into general substance misuse research. This report aimed to examine treatments for alcohol misuse in greater depth in order to determine which approaches were most effective. The review of alcohol treatments in offender settings revealed a small number of highly variable studies, in terms of scope and quality. Indeed, only 6 studies reached the highest level of quality which would usually merit including into a Cochrane review. It was not possible to make direct comparisons between studies due to their differences, but a narrative review provided individual results. Brief psychosocial interventions were shown to be effective in reducing alcohol consumption amongst men in community settings. In offender settings, the results were found to be more mixed. Cognitive Behavioural Therapy (CBT) was shown to be effective in reducing future alcohol use amongst alcohol-dependent domestic abusers in a high quality study from the US. Other positive results were found for driving-whilst-disqualified offenders undergoing CBT or the Turning Point residential programme (but only long term for the latter), as well as an education course for young offenders in the UK. However, ten other interventions showed no significant improvements on future recidivism or alcohol use. The interventions included in this part of the 1314 review varied greatly, and it would be wrong to discount all psycho-social interventions on the basis of the results shown here. Rather, there is a need for future high-quality research in this area, particularly in the use of CBT in the UK, and evaluations of the services provided to prisoners in England and Wales. Alcoholics Anonymous and other 12-step programmes in the community were not supported by the available research evidence. The review of offender treatments showed that no studies had examined this area; another topic ripe for future research given the wide availability of Alcoholics Anonymous groups for prisoners in England and Wales (Hansard, 2007). Some additional treatments were considered in the offender review but not yet subject to Cochrane review. Victim impact panels were found to be successful in only one of four studies. Legal sanctions did show some positive effects, particularly the Ignition Interlock devices which require offenders to provide a breath test before their car can start. There were two studies of therapeutic communities with specific alcohol components, and one of these showed success in future alcohol use. Finally, Vipassana Mindfulness Meditation was effective in reducing alcohol use but not recidivism in a novel study conducted in the US. Possible UK pilot studies of Ignition Interlock and meditation may therefore be indicated. The results from the community showed the success of benzodiazepine for alcohol withdrawal, and naltrexone for alcohol dependence. To date there has been no research on pharmacological treatments for alcohol misuse in offender settings. Again, policy has been dictated by what works in the community but these results should be replicated (particularly in prisons) to fully understand the effects of such treatments. There is clearly a need to conduct clinical trials of new and existing alcoholrelated interventions in the UK. 1415 In summary, this review has highlighted major gaps in the evidence base for substance misuse treatments for offender populations, and made suggestions for areas where future research could usefully focus. 1516 RATIONALE Substance misuse is a major problem in the general population as well as in prisons and the wider Criminal Justice System. Treatments for substance use disorders can benefit the individual in the short term, for example by managing withdrawal symptoms during detoxification, in the longer term, by preventing relapse into drug use, and can also benefit the wider community by reducing reoffending. As with all health-related services, treatments should be provided on the basis of demonstrated efficacy. Furthermore, treatments which are successful in one setting may need to be adapted for another (for example when implementing community-based services into the prison environment). This review aims to examine the efficacy of drug and alcohol treatments in the community and prison environments. This is an area of innovation, with new treatments being developed all the time. Policy and guidance has also had to keep up with the more recent research findings; for example, two new NICE guidelines were published in July Section 1 of this report, therefore, contains a summary of the most recent policy for the treatment of drug and alcohol misuse and dependence in criminal justice and community settings. Whilst there is a large body of evidence for community-based drug treatments, there has been far less research in criminal justice settings. Furthermore, there have been several comprehensive systematic reviews of drug treatment interventions in these populations. These are summarised and the findings compared with Cochrane reviews of community treatments. We have also highlighted gaps in criminal justice drug treatment research, as compared with community research and also current treatment guidance. This is presented in Section 2. In a great deal of research in this field, alcohol problems are subsumed into the larger category of substance misuse. The recent reviews of substance misuse in the prison environment do not report specifically on alcohol misuse. 1617 Therefore, we have conducted a new systematic review of alcohol treatments in offender populations (Section 3). We reviewed the evidence in Cochrane reviews relating to the treatment of alcohol misuse and dependence in the community and concluded by highlighting research gaps in offender research. 1718 Section 1: Review of Current Policy and Guidance 1.1 Prison and Offender There are several policy documents and strategies for the management and treatment of problematic substance users in offender populations. The National Offender Management Service (NOMS) has a strategy relating to problematic drug users in correctional services (NOMS, 2005). HM Prison Service have in place drug and alcohol strategies (HMPS, 2002; HMPS 2003; HMPS, 2006), as well as a good practice guide for alcohol treatment and interventions (HMPS, 2004). The National Probation Service also has a strategy for working with alcohol misusing offenders (National Probation Service, 2006). Finally, the cross-government document Safe. Sensible. Social (2007), updating the national alcohol strategy, contains specific recommendations for offender populations. The HM Prison Service Drug Strategy has as its standard: Staff in establishments work to ensure a continuing reduction in the availability of drugs through a range of supply reduction measures, identify prisoners who are drug misusers, provide them with the opportunity for treatment and support to help them avoid drugs and reduce the risk of them committing drug related crimes after their release. (HMPS, 2002; p1) Key audit baselines relevant to the treatment of prisoners with drug problems are that each establishment has their own strategy detailing: how those with drug problems are identified; provision of treatment, counselling and support, health promotion and harm minimisation; clinical services provided by health care; multi-agency partnerships to support prisoners on release; protocols between CARATs 1 and health care; and staff training. Furthermore, each establishment is expect to have written policies on detoxification (including which services are available, specific guidelines for opiate, alcohol and 1 CARAT (Counselling, Assessment, Referral, Advice and Throughcare) Services are provided in every prison establishment in England and Wales, and are a core part of HM Prison Service Drugs Strategy. 1819 benzodiazepine detoxification, assessment, and treatment settings), CARAT services (including making prisoners aware of the service, communication with other departments, assessment, the provision of counselling/groupwork, and the presence of release plans). Finally, the strategy states that rehabilitation programmes and therapeutic communities should be provided for those assessed as requiring them. The subsequent briefing paper (HMPS, 2003) stated: Although every aspect of the Drug Strategy is collectively important, the main focus of the Service s work currently falls on drug treatment interventions. (p4) The paper then described the three main initiatives; CARATs, detoxification, and rehabilitation programmes. CARATs was defined as a low-level intervention with individualised care plans. There was an emphasis on throughcare, such that treatments were provided at all stages of the Criminal Justice System, and that links were established with community treatment providers. In detoxification, the paper suggested that HM Prison Service favours detoxification over maintenance prescribing, though acknowledging that maintenance is appropriate for those on remand or serving short sentences who have been successfully maintained in the community. An emphasis was placed on harm minimisation for prisoners at risk of lethal overdose on release, to be delivered by CARATs in the form of counselling and education. The strategy did not specify preferred medications for detoxification. The rehabilitation programmes described in the paper were cognitivebehavioural therapy, 12-step approaches, and therapeutic communities. A list of accredited 2 offending behaviour programmes relating to substance misuse can be found in Appendix 1. PASRO is a fast-growing CBT-based programme 2 Offending Behaviour Programmes are accredited by the Correctional Services Accreditation Panel which advises the Ministry of Justice on the basis of demonstrated efficacy. 1920 which recently received accreditation. At the time of writing (2003), there were estimates that around 30-40% of need was being met and that 7,600 places on rehabilitation programmes were expected to have been provided by Emerging evidence was also outlined into the beneficial effects of rehabilitation programmes on reoffending rates. In 2006, Department of Health published a document called Clinical Management of Drug Dependence in the Adult Prison Setting (DH, 2006), which set out how prison-based drug and alcohol services for adults should develop in the next two years. Guidance on services for younger people is not yet published. The document specifies five challenges currently faced by substance misuse services, these being: Vulnerability to suicide and self harm in prison and accidental overdose on release Illicit drug use in prison Providing services which meet national and international good practice Providing services in line with those in the community and other criminal justice settings Integration of CARAT services to create multi-disciplinary drug teams The principle of the guidance was withdrawal prescribing, informed by screening and assessment. For opioid dependence, the guidance stated: Opiate-dependent prisoners should be stabilised on licensed opiate substitute medication for a minimum of five days to enable withdrawal symptoms to be adequately controlled (p14) Stabilisation can be methadone or buprenorphine, the dose titrated in response to withdrawal symptoms. Following stabilisation three treatment 20 View more
Bringing evidence and analysis together to inform UK drug policy Reducing Drug Use, Reducing Reoffending Are programmes for problem drug-using offenders in the UK supported by the evidence? Summary Over More information Treatments for drug misuse
Understanding NICE guidance Information for people who use NHS services Treatments for drug misuse NICE clinical guidelines advise the NHS on caring for people with specific conditions or diseases and More information Alcohol and Drug. A Cochrane Handbook. losief Abraha MD. Cristina Cusi MD. Regional Health Perugia
Alcohol and Drug A Cochrane Handbook losief Abraha MD Regional Health Perugia of Cristina Cusi MD Outpatient Services - Neurology Clinical Institutes of Specialisation Milan Italy A John Sons, Ltd., THE More information National Offender Management Service NOMS Reducing Re-offending: Drug and Alcohol Treatment Strategy
National Offender Management Service NOMS Reducing Re-offending: Drug and Alcohol Treatment Strategy Danny Clark, Head of Substance Misuse interventions Reducing Re-offending Policy Group Directorate of More information NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SPECIAL HEALTH AUTHORITY TENTH WAVE WORK PROGRAMME DRUG MISUSE. Psychosocial interventions in drug misuse
Attachment B NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SPECIAL HEALTH AUTHORITY TENTH WAVE WORK PROGRAMME DRUG MISUSE Psychosocial interventions in drug misuse On 16 th June 2004 the Department of Health More information Costing report. Drug misuse: psychosocial interventions and opioid detoxification. Implementing NICE guidance. July 2007
Drug misuse: psychosocial interventions and opioid detoxification Costing report Implementing NICE guidance July 2007 NICE clinical guidelines 51 and 52 National costing report: Drug misuse guidelines More information Phoenix Futures Prison Treatment programmes
Phoenix Futures Prison Treatment programmes Karen Biggs Chief Executive, Phoenix Futures Overview of Presentation Political and Strategic context in England Overview of some of our programmes. Outcomes More information REVIEW OF DRUG TREATMENT AND REHABILITATION SERVICES: SUMMARY AND ACTIONS
REVIEW OF DRUG TREATMENT AND REHABILITATION SERVICES: SUMMARY AND ACTIONS 1. INTRODUCTION 1.1 Review Process A Partnership for a Better Scotland committed the Scottish Executive to reviewing and investing More information No.1 Why reducing drug-related crime is important, and why the new government needs to act
RAPt RESEARCH AND POLICY BRIEFING SERIES No.1 Why reducing drug-related crime is important, and why the new government needs to act 12th May 2015 FOREWORD This series of RAPt Research and Policy Briefings More information The effectiveness of criminal justice and treatment programmes in reducing drugrelated. a systematic review
The effectiveness of criminal justice and treatment programmes in reducing drugrelated crime: a systematic review Katy Holloway Trevor Bennett David Farrington Home Office Online Report 26/5 The views More information SPECIFICATION FOR THE LOCAL COMMISSIONED SERVICE FOR THE MANAGEMENT ALCOHOL MISUSE
SPECIFICATION FOR THE LOCAL COMMISSIONED SERVICE FOR THE MANAGEMENT OF ALCOHOL MISUSE Date: March 2015 1 1. Introduction Alcohol misuse is a major public health problem in Camden with high rates of hospital More information Substance Misuse Treatment Framework (SMTF) Guidance for Evidence Based Psychosocial Interventions in the Treatment of Substance Misuse
Substance Misuse Treatment Framework (SMTF) Guidance for Evidence Based Psychosocial Interventions in the Treatment of Substance Misuse ISBN 978 0 7504 6272 3 Crown copyright 2011 WG-12567 F9161011 Contents More information drug treatment in england: the road to recovery
The use of illegal drugs in England is declining; people who need help to overcome drug dependency are getting it quicker; and more are completing their treatment and recovering drug treatment in ENGlaND: More information POWDER COCAINE: HOW THE TREATMENT SYSTEM IS RESPONDING TO A GROWING PROBLEM
Effective treatment is available for people who have a powder-cocaine problem seven in ten of those who come into treatment either stop using or reduce their use substantially within six months POWDER More information Criminal Justice Integrated Drug Teams and treatment interventions. Clinical guidance to maximise access to drug treatment
Criminal Justice Integrated Drug Teams and treatment interventions Clinical guidance to maximise access to drug treatment November 2003 NTA Clinical Guidance to CJIP Teams Nov O3 Page 1 of 17 1. Introduction More information Resources for the Prevention and Treatment of Substance Use Disorders
Resources for the Prevention and Treatment of Substance Use Disorders Table of Contents Age-standardized DALYs, alcohol and drug use disorders, per 100 000 Age-standardized death rates, alcohol and drug More information SCOTTISH PRISON SERVICE DRUG MISUSE AND DEPENDENCE OPERATIONAL GUIDANCE
SCOTTISH PRISON SERVICE DRUG MISUSE AND DEPENDENCE OPERATIONAL GUIDANCE 1 P a g e The following Operational Guidance Manual has been prepared with input from both community and prison addictions specialists More information Substance Misuse Treatment Framework (SMTF) Guidance for the Provision of Evidence Based Tier 4 Services in the Treatment of Substance Misuse
Substance Misuse Treatment Framework (SMTF) Guidance for the Provision of Evidence Based Tier 4 Services in the Treatment of Substance Misuse ISBN 978 0 7504 6273 0 Crown copyright 2011 WG-12567 F9161011 More information DrugFacts: Treatment Approaches for Drug Addiction
DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please More information Medications for Alcohol and Drug Dependence Treatment
Medications for Alcohol and Drug Dependence Treatment Robert P. Schwartz, M.D. Medical Director Rschwartz@friendsresearch.org Friends Research Institute Medications for Alcohol Dependence Treatment Disulfiram More information Impact of Systematic Review on Health Services: The US Experience
Impact of Systematic Review on Health Services: The US Experience Walter Ling MD Integrated Substance Abuse Programs (ISAP) UCLA The effectiveness of interventions for addictions: The Drug and Alcohol More information Treatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction [NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call More information Summary: Analysis & Evidence Policy Option 1 Description: Offender Rehabilitation Bill FULL ECONOMIC ASSESSMENT
Title: Offender Rehabilitation Bill Impact Assessment IA : Lead department or agency: Ministry of Justice Other departments or agencies: NOMS Summary: Intervention and Options Impact Assessment (IA) Date: More information Adult drug treatment plan 2007/08 Part 1 Section A: Strategic summary Section B: National targets Section C: Partnership performance expectations
name Adult drug treatment plan Part 1 Section A: Strategic summary Section B: National targets Section C: expectations Published by NTA: 2 October This strategic summary incorporating national targets More information HEAT A11: Updated Drug and Alcohol Treatment Types
HEAT A11: Updated Drug and Alcohol Treatment Types 2010 Authored by: Hilary Smith and Mike Massaro-Mallinson HEAT A11: Updated Drug and Alcohol Treatment Types Contents INTRODUCTION 2 PRIOR TO STAGE (1) More information Current Model of Drug Care. Components of a Full Drug Care Service
Current Model of Drug Care Treatment Detox Rehab Components of a Full Drug Care Service (1) (2) (3) (4) (5) (6) (7) (8) (9) Community Preparation Treatment Detox Rehab Community Community Prison work Halfway More information This factsheets covers:
Healthcare in Prison Prisoners should have the same access to healthcare services as everyone else. This factsheet looks at what health services you can get if you are in prison and what to do if you are More information Alcohol and Re-offending Who Cares?
January 2004 Alcohol and Re-offending Who Cares? This briefing paper focuses on the high level of alcohol misuse and dependence within the prison population. In recent years a great deal of time and money More information Integrated drug treatment system Treatment plan 2009/10. Part 1: Strategic summary, needs assessment and key priorities
Establishment: HMP Belmarsh Drugs partnership: Greenwich Primary Care Trust: Greenwich Integrated drug treatment system Treatment plan 2009/10 Part 1: Strategic summary, needs assessment and key priorities More information Models of care for treatment of adult drug misusers: Update 2006
Models of care for treatment of adult drug misusers: Update 2006 National Treatment Agency for Substance Misuse July 2006 The National Treatment Agency for Substance Misuse The National Treatment Agency More information Substance Misuse Treatment Framework (SMTF) Guidance for Evidence Based Community Prescribing in the Treatment of Substance Misuse
Substance Misuse Treatment Framework (SMTF) Guidance for Evidence Based Community Prescribing in the Treatment of Substance Misuse ISBN 978 0 7504 6271 6 Crown copyright 2011 WG-12567 F9161011 Contents More information Treatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357) More information DMRI Drug Misuse Research Initiative
DMRI Drug Misuse Research Initiative Executive Summary Dexamphetamine Substitution as a Treatment of Amphetamine Dependence: a Two-Centre Randomised Controlled Trial Final Report submitted to the Department More information 4. How does your city fit into the political-administrative structure of your country? Total Partial None. 5. Demographics
. City.Country. Official responsible for providing this information (mandatory) a. Name b. Position Official title c. Institution Name of the institution where you work d. Address Complete postal address More information Milton Keynes Drug and Alcohol Strategy 2014-17
Health and Wellbeing Board Milton Keynes Drug and Alcohol Strategy 2014-17 www.milton-keynes.gov.uk 2 Contents Foreword 4 Introduction 5 National context 6 Local context 7 Values and principles 9 Priorities More information Principles for commissioning a substance misuse treatment system
Developing Recovery Communities: Treatment Plan Strategic Summary 2013/14 East Sussex Drug and Alcohol Action Team 1. The East Sussex Drug and Alcohol Action Team (DAAT) is the multi-agency partnership More information Guidance for the Planning and Provision of Substance Misuse Services to Children and Young People in the Care of Youth Offending Services
Guidance for the Planning and Provision of Substance Misuse Services to Children and Young People in the Care of Youth Offending Services ISBN 978 0 7504 5453 7 Crown copyright December 2009 CMK-22-04-045(423) More information Treatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call the More information Executive Member for Community Health and Wellbeing. Commissioned Alcohol Services and Current Performance Update
TRAFFORD COUNCIL Report to: Health Scrutiny Committee Date: February 2014 Report of: Executive Member for Community Health and Wellbeing Report Title Commissioned Alcohol Services and Current Performance More information DRUG AND ALCOHOL DETOXIFICATION: A GUIDE TO OUR SERVICES
01736 850006 www.bosencefarm.co.uk DRUG AND ALCOHOL DETOXIFICATION: A GUIDE TO OUR SERVICES An environment for change Boswyns provides medically-led drug and alcohol assessment, detoxification and stabilisation. More information Drug Interventions Programme Operational Handbook
Drug Interventions Programme Operational Handbook Foreword The Drug Interventions Programme Operational Handbook is part of our programme of work to continuously improve the implementation of, and outcomes More information Opioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription More information THE STORY OF DRUG TREATMENT
THE STORY OF DRUG TREATMENT EFFECTIVE TREATMENT CHANGING LIVES The story of drug treatment The goal of all treatment is for drug users to achieve abstinence from their drug or drugs of dependency. For More information ONDCP. Drug Policy Information Clearinghouse FACT SHEET John P. Walters, Director www.whitehousedrugpolicy.gov 1-800-666-3332
UNUM Executive Office of the President Office of National Drug Control Policy E PLURIBUS OFFICE OF NATIONAL POLICY D RUG CONTROL ONDCP March 2001 Drug Policy Information Clearinghouse FACT SHEET John P. More information Directory for Substance Misuse Services in Caerphilly
Directory for Substance Misuse s in Caerphilly Background Substance Misuse services use a tiered approach in their approach and delivering of drug/alcohol services. These are as follows: Tier 1 Interventions More information National Drug Treatment Monitoring System (NDTMS) NDTMS DATA SET J
National Drug Treatment Monitoring System (NDTMS) NDTMS DATA SET J IMPLEMENTATION GUIDE FOR ADULT DRUG AND ALCOHOL TREATMENT PROVIDERS Author S Taylor Approver J Knight Date 10/7/12 Version 2.0 REVISION More information Dual Diagnosis: Models of Care and Local Pathways AGENDA. Part one: Part two:
Slide 1 Dual Diagnosis: Models of Care and Local Pathways St. Anne s Community Services Dual Diagnosis Project Slide 2 AGENDA Part one: Models of Care. Clinical Guidelines & Evidence Base Local Care Pathways More information Consultation Paper on Commissioning Adults and Young People s Drug and Alcohol Services in Somerset
Consultation Paper on Commissioning Adults and Young People s Drug and Alcohol Services in Somerset Date: September 2012 Authors: SDAP Staff Team Closing Date for Consultation Submissions: Friday 2 nd More information Developing the Guernsey treatment system for substance misusers: Phases One and Two. Helen Baldwin Linda Prickett Adam Marr Jim McVeigh
Developing the Guernsey treatment system for substance misusers: Phases One and Two Helen Baldwin Linda Prickett Adam Marr Jim McVeigh Roles and responsibilities of the LJMU research team Helen Baldwin More information Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:
Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society More information EPIDEMIOLOGY OF OPIATE USE
Opiate Dependence EPIDEMIOLOGY OF OPIATE USE Difficult to estimate true extent of opiate dependence Based on National Survey of Health and Mental Well Being: 1.2% sample used opiates in last 12 months More information Drug and Alcohol Agency Action Plan 2010 2014
Drug and Alcohol Agency Action Plan 2010 2014 Making a positive difference. CONTENTS INTRODUCTION...3 OBJECTIVES...4 STRATEGY 1: FOCUSING ON PREVENTION...5 STRATEGY 2: INTERVENING BEFORE PROBLEMS BECOME More information The story of drug treatment
EFFECTIVE TREATMENT CHANGING LIVES www.nta.nhs.uk www.nta.nhs.uk 1 The story of drug treatment The use of illicit drugs is declining in England; more and more people who need help with drug dependency More information The Use of Non-Opioid Pharmacotherapies. for the Treatment of Alcohol Dependence
M00K02 Alcohol and Drug Abuse Administration Department of Health and Mental Hygiene The Use of Non-Opioid Pharmacotherapies for the Treatment of Alcohol Dependence Introduction The 2011 Joint Chairmen More information Locally Enhanced Service for a practice-based Alcohol Monitoring, Withdrawal and Detoxification Service
08/09 Locally Enhanced Service for a practice-based Alcohol Monitoring, Withdrawal and Detoxification Service Reference: LES24 Contents: 1. Finance Details 2. Service Aims 3. Service Criteria 4. Ongoing More information Non medical use of prescription medicines existing WHO advice
Non medical use of prescription medicines existing WHO advice Nicolas Clark Management of Substance Abuse Team WHO, Geneva Vienna, June 2010 clarkn@who.int Medical and Pharmaceutical role Recommendations More information Questions to ask before going to rehab by Rehab-Programs.org 2011
Table of Contents Questions to Ask Before Going to Rehab... 1 Do I really need to check into an inpatient drug rehab center?... 2 How long will I stay in the rehab center?... 2 What is the track record More information Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence
Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence Issued: February 2011 guidance.nice.org.uk/cg115 NICE has accredited the process used by the Centre More information National Drug Treatment Monitoring System (NDTMS) NDTMS DATA SET H
National Drug Treatment Monitoring System (NDTMS) NDTMS DATA SET H BUSINESS DEFINITION FOR ADULT DRUG TREATMENT PROVIDERS Author M. Hinchcliffe Approver M. Roxburgh Date 01/03/2011 Version 8.03 REVISION More information (Health Scrutiny Sub-Committee 9 March 2009)
Somerset County Council Health Scrutiny Sub-Committee 9 March 2009 Drug and Alcohol Treatment Services Author: Amanda Payne Somerset DAAT Co-ordinator Contact Details: Amanda.Payne@somerset.nhs.uk Paper More information Islington JSNA 2010/11 Substance Misuse
Islington JSNA 2010/11 Substance Misuse INTRODUCTION Substance misuse is strongly associated with poverty and deprivation. Rates of substance misuse are particularly high in London compared with other More information Frequently Asked Questions (FAQs) of Drug Abuse Treatment for Criminal Justice Populations
Frequently Asked Questions (FAQs) of Drug Abuse Treatment for Criminal Justice Populations From The National Institute on Drug Abuse (NIDA) 2. Why should drug abuse treatment be provided to offenders? More information MAKING RECOVERY REAL: THE PUBLIC HEALTH FUTURE OF DRUG AND ALCOHOL TREATMENT
MAKING RECOVERY REAL: THE PUBLIC HEALTH FUTURE OF DRUG AND ALCOHOL TREATMENT Drug treatment in England: a decade of achievement Overall drug use in England is down There are fewer heroin and crack users More information A LONG-TERM STUDY OF THE OUTCOMES OF DRUG USERS LEAVING TREATMENT SEPTEMBER 2010
National Treatment Agency for Substance Misuse Long-term results for those who have been treated in one year found that nearly half who leave neither need further treatment nor were found to be involved More information Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio
Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14, More information Statistics from the National Drug Treatment Monitoring System (NDTMS) Statistics relating to young people England, 1 April 2010 31 March 2011
Statistics from the National Drug Treatment Monitoring System (NDTMS) Statistics relating to young people England, 1 April 2010 31 March 2011 8 December 2011 Executive Summary 21,955 young people accessed More information The National Community Detoxification Pilot
The National Community Detoxification Pilot Aoife Dermody, Progression Routes Initiative NDCI, 2011 Community Detoxification Protocols Guidelines for outpatient detoxification from methadone or benzodiazepines More information SOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011
SOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011 This document is intended to be used with the Somerset Dual Diagnosis Operational Working guide. This document provides principles governing joint working More information Sheffield Future Commissioning of Drug & Alcohol Community Treatment
Sheffield Future Commissioning of Drug & Alcohol Community Treatment Magdalena Boo, Joint Commissioning Manager Scope of the Plan IN SCOPE Adults 18+ (young people s services are separately commissioned) More information FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma
FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma Background A growing opiate abuse epidemic has highlighted the need for effective treatment options. This study documents More information About drugs. Psychoactive drugs. Drugs are substances that change a person s physical or mental state.
1 About drugs Drugs are substances that change a person s physical or mental state. The vast majority of drugs are used to treat medical conditions, both physical and mental. Some, however, are used outside More information Detox Day. RCGP June 13 th 2006. Daphne Rumball Addictions Psychiatrist. Norfolk. Daphne Rumball RCGP Detox Day June 2006 1
Detox Day RCGP June 13 th 2006 Daphne Rumball Addictions Psychiatrist Norfolk Daphne Rumball RCGP Detox Day June 2006 1 Scope of presentation Undertaking detox in the community A review of evidence and More information Welcome. This presentation is designed for people working in criminal justice and drug abuse treatment settings. It provides an overview of drug
Welcome. This presentation is designed for people working in criminal justice and drug abuse treatment settings. It provides an overview of drug abuse treatment principles for individuals involved in the More information Overview of the Breaking Free research and evaluation programme. Based on the MRC framework for developing and evaluating complex interventions
Overview of the Breaking Free research and evaluation programme Based on the MRC framework for developing and evaluating complex interventions June 2015 1 Overview of the Breaking Free research and evaluation More information Research Note RN 00/91 1 November 2000 DRUG COURTS
Research Note RN 00/91 1 November 2000 DRUG COURTS There will be a Scottish National Party debate on Drug Courts on Thursday 2 November 2000. This brief research note gives information on the background More information No.3 A successful approach to tackling drug-related crime
RAPt RESEARCH AND POLICY BRIEFING SERIES No.3 A successful approach to tackling drug-related crime 12th May 2015 FOREWORD This series of RAPt Research and Policy Briefings aims to synthesise over 20 years More information Queensland Corrective Services Drug and Alcohol Policy
Queensland Corrective Services Drug and Alcohol Policy 2727QCS Commissioner s Foreword Drug and alcohol abuse is a significant issue confronting not only Queensland Corrective Services (QCS), but the entire More information Alcohol Dependence and Motivational Interviewing
Alcohol Dependence and Motivational Interviewing Assessment of Alcohol Misuse Checklist Establish rapport patients are often resistant Longitudinal history of alcohol use Assess additional drug use Establish More information Getting help for a drug problem A guide to treatment
Getting help for a drug problem A guide to treatment Who we are The National Treatment Agency for Substance Misuse is part of the National Health Service. We were set up in 2001 to increase the numbers More information Integrated drug treatment system Treatment plan 2010/11. Part 1: Strategic summary, needs assessment and key priorities
Her Majesty s Prison Erlestoke Wiltshire Community Safety Partnership NHS Wiltshire Integrated drug treatment system Treatment plan 2010/11 Part 1: Strategic summary, needs assessment and key priorities More information Addressing Alcohol and Drugs in the Community. Cabinet member: Cllr Keith Humphries - Public Health and Protection Services
Wiltshire Council Cabinet 17 April 2012 Subject: Addressing Alcohol and Drugs in the Community Cabinet member: Cllr Keith Humphries - Public Health and Protection Services Key Decision: Yes Executive Summary More information THE INDEPENDENCE INITIATIVE: AN EVALUATION OF EFFECTIVENESS EXECUTIVE SUMMARY Jim McVeigh & Paul Duffy. Foreword
THE INDEPENDENCE INITIATIVE: AN EVALUATION OF EFFECTIVENESS EXECUTIVE SUMMARY Jim McVeigh & Paul Duffy Foreword The Initiative is a Merseyside wide but Sefton based relapse prevention service that deals More information Treatment for Addiction in the Community Reduces Drug Use, Crime and Recidivism
Treatment for Addiction in the Community Reduces Drug Use, Crime and Recidivism Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School of Medicine University More information TREATMENTS OF SUBSTANCE USE DISORDERS THE SYSTEMATIC REVIEWS OF THE COCHRANE DRUGS AND ALCOHOL GROUP (CDAG)
TREATMENTS OF SUBSTANCE USE DISORDERS THE SYSTEMATIC REVIEWS OF THE COCHRANE DRUGS AND ALCOHOL GROUP (CDAG) Laura Amato, Marina Davoli, Simona Vecchi, Carlo A Perucci Updated June 2005 THE COCHRANE COLLABORATION More information THE MAGISTRATES EARLY REFERRAL INTO TREATMENT PROGRAM EVALUATION AND 'REAL WORLD' CHALLENGES
THE MAGISTRATES EARLY REFERRAL INTO TREATMENT PROGRAM EVALUATION AND 'REAL WORLD' CHALLENGES Jane Bolitho, Sandra Crawford and Bruce Flaherty Crime Prevention Division, NSW Attorney General's Department More information The Recovery Pathway Service forms a key component of the Sunderland Integrated Substance Misuse Service, as illustrated below:
SERVICE SPECIFICATION LOT 1 RECOVERY PATHWAY 1.0 SERVICE MODEL The Recovery Pathway Service forms a key component of the Sunderland Integrated Substance Misuse Service, as illustrated below: Recovery Outcomes More information Medication Assisted Treatment For Opiate Addiction in Correctional Settings
Medication Assisted Treatment For Opiate Addiction in Correctional Settings Jeff Baxter, MD Dept. of Family Medicine UMASS Medical School Joshua Lee, MD, MS Dept. of General Internal Medicine New York More information DETOXING THE DEPENDENT DRINKER ON METHADONE JEFF FERNANDEZ NURSE CONSULTANT FOR SUBSTANCE MISUSE ISLINGTON
DETOXING THE DEPENDENT DRINKER ON METHADONE JEFF FERNANDEZ NURSE CONSULTANT FOR SUBSTANCE MISUSE ISLINGTON BACKGROUND Substance misuse services Prescribing conducted by: IDASS PCADS ISIS Tier two provision: More information Adult drug treatment plan 2009/10. Part 1: Strategic summary, needs assessment and key priorities
Birmingham Drug and Alcohol Action Team Adult drug treatment plan 2009/10 Part 1: Strategic summary, needs assessment and key priorities The strategic summary incorporating the findings of the needs assessment, More information Heroin Addicted Offenders. Centre for Clinical Research
Legally Coerced Treatment for Heroin Addicted Offenders Wayne Hall and Jayne Lucke University of Queensland Centre for Clinical Research Outline What is legally coerced addiction treatment? Case for such More information Chapter 11 The role of healthcare professionals
Chapter 11 The role of healthcare professionals 11.1 Introduction There are three levels at which doctors are involved in responding to illicit drugs. All doctors in clinical practice will encounter patients More information Evidence Based Practice in the Treatment of Addiction Treatment of Addiction. Steve Hanson
Evidence Based Practice in the Treatment of Addiction Treatment of Addiction Steve Hanson History of Addiction Treatment Incarceration Medical Techniques Asylums What We Learned These didn t work Needed More information Care Management Council submission date: August 2013. Contact Information
Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing More information DRUG AND ALCOHOL MISUSE AMONG ADULT OFFENDERS ON PROBATION SUPERVISION IN IRELAND. Findings from the Drugs and Alcohol Survey 2011
DRUG AND ALCOHOL MISUSE AMONG ADULT OFFENDERS ON PROBATION SUPERVISION IN IRELAND Findings from the Drugs and Alcohol Survey 2011 Probation Service Research Report May 2012 Acknowledgements I would like More information Injectable heroin (and injectable methadone) Potential roles in drug treatment
Injectable heroin (and injectable methadone) Potential roles in drug treatment Full guidance report May 2003 National Treatment Agency More treatment, better treatment, fairer treatment The National Treatment More information Alcohol-use disorders
Issue date: February 2011 Alcohol-use disorders Diagnosis, assessment and management of harmful drinking and alcohol dependence Alcohol dependence: NICE guideline FINAL DRAFT (February 2011) 1 NICE clinical More information Use of Pharmacotherapies by Substance Abuse Treatment Facilities
Use of Pharmacotherapies by Substance Abuse Treatment Facilities Cathie E. Alderks, PhD Substance Abuse and Mental Health Services Administration Department of Health and Human Services November 2007 1 More information Care planning practice guide
National Treatment Agency for Substance Misuse August 2006 2 The National Treatment Agency for Substance Misuse The National Treatment Agency for Substance Misuse (NTA) is a special health authority within More information The Drug Treatment and Testing Order: early lessons. REPORT BY THE COMPTROLLER AND AUDITOR GENERAL HC 366 Session 2003-2004: 26 March 2004
The Drug Treatment and Testing Order: early lessons REPORT BY THE COMPTROLLER AND AUDITOR GENERAL HC 366 Session 2003-2004: 26 March 2004 The National Audit Office scrutinises public spending on behalf More information Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation
Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation Cynthia Caporizzo, Senior Criminal Justice Advisor, Office of National Drug Control Policy (ONDCP) - Review of the administration More information 2017 © DocPlayer.net Privacy Policy | Terms of Service | Feedback